BlaidsX Neuro vs Phonak Audéo Lumity

The BlaidsX Neuro is a mid-priced behind-the-ear OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This places it in the top 68% of OTC hearing aids tested, though it falls below the category average of 3.71. In our testing, the BlaidsX Neuro showed notable strengths in speech clarity for quiet environments, scoring 0.54 points above the category average. Feedback handling was excellent at 5.0/5, ranking among the best we've measured and 0.46 points above average. These results suggest the device may work well for conversations in calm settings where background noise isn't a factor. However, the device showed significant limitations in other areas. Speech in noise performance scored low at 1.0/5, falling 0.48 points below the category average—a concern for users who need help in challenging listening environments. Own-voice comfort also scored below average at 1.7/5, and music streaming scored 0.0/5, making it unsuitable for those who want to stream audio content. At this price point, buyers face strong competition. Devices like the Sony CRE-E10 and Lexie B2 Plus offer substantially higher overall scores in the same price range. The BlaidsX Neuro may suit users who primarily need help with face-to-face conversation in quiet spaces and don't require streaming capabilities, but those seeking versatile performance should consider alternatives.

The Phonak Audéo Lumity is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,398. In HearAdvisor's lab testing, it earned a SoundScore of 4.1/5 (A grade), ranking #21 of 36 prescription hearing aids tested. This device demonstrates clear strengths in specific performance areas. Music streaming quality is strong at 4.1/5, scoring 1.46 points above the category average—a notable advantage for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, meaning the Lumity maintained stability without audible feedback during our standardized challenge tests. Speech in quiet environments also performs solidly at 3.7/5, measuring 0.37 points above the prescription category average. However, the Lumity shows a significant weakness in own-voice comfort, scoring just 1.0/5—a full 1.75 points below the category average. This low score suggests users may notice more occlusion or an unnatural quality to their own voice. Speech in noise performance is mixed at 2.1/5; while this is slightly above the category average (+0.19 points), it remains modest in absolute terms. The Audéo Lumity is best suited for users who prioritize excellent streaming quality and reliable feedback control, and who are less sensitive to own-voice occlusion effects. Those who struggle primarily with speech understanding in noisy environments may want to compare against higher-scoring competitors in this price range, such as the Phonak Sphere Infinio or Oticon Intent.